Prescription Required
Authentic Product
India's Leading Generic Pharmacy
Secure Payment
By PFIZER PHARMACEUTICAL INDIA PRIVATE LIMITED
MRP
₹
5710
₹4568
20 % OFF
₹326.29 Only /
Tablet
Check Delivery
--
Composition
XELJANZ 5MG TABLET 14'S can cause side effects, which are unwanted symptoms from the medicine. Not everyone gets these side effects, even though all medicines can cause them.
Pregnancy
UNSAFEXELJANZ 5MG TABLET 14'S is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for at least 4 weeks after your last dose is necessary.
Tell your doctor immediately if you start to have swelling of your face, lips, tongue, throat, arms, or legs or if you are having trouble swallowing or breathing. XELJANZ 5MG TABLET 14'S can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection.
Increased cholesterol levels are one of the side effects of XELJANZ 5MG TABLET 14'S, your doctor may take regular blood tests to check for serious side effects.
No, XELJANZ 5MG TABLET 14'S does not cause depression. However, many people who have autoimmune conditions also have symptoms of depression. If you're having symptoms of depression, see your doctor right away.
Yes, blood clots are reported in patients using XELJANZ 5MG TABLET 14'S for a longer period. Inform your physician if you face any symptoms of a blood clot.
XELJANZ 5MG TABLET 14'S is a long-term treatment. Most people who benefit from this treatment will notice an improvement in the first 12 weeks of starting treatment.
XELJANZ 5MG TABLET 14'S may interfere with vaccines, inform your doctor about your vaccination history. It may impair fertility; discuss this with your doctor. Your doctor will regularly do lab tests. It can make you bleed, bruise, or get infections more easily, so take precautions. Do not breastfeed during treatment and for at least 36 hours after your last dose.
XELJANZ 5MG TABLET 14'S may impair fertility; discuss this with your doctor. Do not breastfeed during treatment and for at least 36 hours after your last dose. Inform your doctor about your vaccination history as the medicine may interfere with vaccines.
The active ingredient in XELJANZ 5MG TABLET 14'S is TOFACITINIB.
XELJANZ 5MG TABLET 14'S is used to treat conditions such as Arthritis and Osteoporosis.
Yes, XELJANZ 5MG TABLET 14'S is used in the treatment of Arthritis.
Yes, XELJANZ 5MG TABLET 14'S is used in the treatment of Osteoporosis.
Good discounts available for all medicine.
Akash Patel
•
Reviewed on 01-12-2023
(4/5)
Awesome experience every time i get medicine on time and they have delivery on time also staff are very cooperative and knowledgeable
Tarun Ezava
•
Reviewed on 22-06-2023
(5/5)
Medkart is a healthcare platform that educates people in India about generic medicines. its very Good work, keep it up.
jayswal sachin
•
Reviewed on 18-01-2024
(5/5)
It's a seamless experience.
Mitula Patel
•
Reviewed on 08-01-2024
(5/5)
Tarif / Service is good
Venkataramanamurty Inguva
•
Reviewed on 15-07-2023
(5/5)
PFIZER PHARMACEUTICAL INDIA PRIVATE LIMITED
Country of Origin -
India
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
©2025 Medkart Pharmacy. All Rights Reserved
